Any current/future capex/capital investment/strategic investment?

The company is continuously evaluating various capex plans and growth initiatives but has not finalized anything yet. Once a plan is approved by the Board, the company will announce it. Current capex is under study with a focus on where investments are needed, including potential new products and expansions. Expansion is considered when capacity utilization reaches around 70%-75%, but no immediate plans have been finalized. The company is also exploring other adjacencies outside its core business but no definite timeline is available for such initiatives. Maintenance capex is ongoing, but exac

Future growth expectations in sales/revenue/volumes?

Volumes expected to increase gradually from FY '25 onwards with positive buildup in export approvals and domestic demand (Pages 5, 6, 9, 15, 16). Domestic tire market projected to grow at 3%-6% CAGR from FY '24 to '26 driven by replacement and OE sales (Page 4). Exports currently about 34% of revenue with growth aspirations, especially through global customer approvals and new volumes (Pages 14, 16). Specialty segment currently 15%-17% of sales with aspirations to grow its share (Page 7, 15). Capacity utilization in specialized applications is at 62%-65%; expansion plans under evaluation (Page

Future growth expectations in earnings/operating earnings/profits/EPS?

Management expects volume growth going forward, driven by domestic market recovery and export approvals accelerating. The domestic tire market is projected to grow at a CAGR of 3-6% from FY '24 to '26, supporting demand growth for rubber chemicals. Incremental volumes are expected from new product approvals and capacity expansions starting FY '25. Operating EBITDA margins held steady at about 14% in Q3 FY '24; long-term spreads and valuation additions are expected to be maintained despite raw material price volatility. Export volume growth and domestic market expansion are key drivers for earn

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders. However, V.S. Anand stated that they have been making progress with global tire customers and have incremental volumes starting to accrue from new approvals. New approvals are coming from both US and European markets, indicating positive momentum in order inflows. There is an expectation of gradual volume buildup from Q4 FY'24 and into FY'25. Discussions with customers are ongoing, and the company is cautiously optimistic about growth in export volumes. No specific quantitative details on order boo

NOCIL LtdQ3 FY24Chemicals & Petrochemicals

NOCIL Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹145.35P/E: 34.9Market Cap: ₹2.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Volumes expected to increase gradually from FY '25 onwards with positive buildup in export approvals and domestic demand (Pages 5, 6, 9, 15, 16).
Domestic tire market projected to grow at 3%-6% CAGR from FY '24 to '26 driven by replacement and OE sales (Page 4).
Exports currently about 34% of revenue with growth aspirations, especially through global customer approvals and new volumes (Pages 14, 16).
Specialty segment currently 15%-17% of sales with aspirations to grow its share (Page 7, 15).
Capacity utilization in specialized applications is at 62%-65%; expansion plans under evaluation (Page 16).
Market share expected to grow marginally above market growth rates domestically (Page 6).
Incremental volumes expected from expanded capacities and new customer approvals starting Q4 FY '24 through FY '25 (Page 5).
Revenue and volume growth may face near-term volatility due to raw material price fluctuations and external economic factors (Pages 7, 9).

Margin guidance

Category 3

Management expects volume growth going forward, driven by domestic market recovery and export approvals accelerating.
The domestic tire market is projected to grow at a CAGR of 3-6% from FY '24 to '26, supporting demand growth for rubber chemicals.
Incremental volumes are expected from new product approvals and capacity expansions starting FY '25.
Operating EBITDA margins held steady at about 14% in Q3 FY '24; long-term spreads and valuation additions are expected to be maintained despite raw material price volatility.
Export volume growth and domestic market expansion are key drivers for earnings growth.
Management maintains a positive outlook for volume and profit ascent but refrains from specific near-term numeric guidance.
Capital expenditure plans are under evaluation to support growth; no expansion imminent until plans are finalized and approved.
Overall, the company is optimistic about earnings growth driven by volume increases and operational efficiencies.

See what NOCIL Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- NOCIL Limited is currently evaluating various capital expenditure (capex) plans. - No finalized decisions on expansion or new fundraising have been made yet. - When any plan is finalized, it will be presented to the Board for approval. - The company did not provide specific details on the size or nature (debt or equity) of potential fundraising. - The aspiration to grow and invest is definitely there, and plans are under consideration. - Any announcements regarding capital allocation or fundraising will be communicated once the Board approves the plans. (Source: Page 9 and Page 16 of the transcript)

Order book

The transcript does not explicitly mention the current or expected order book or pending orders.
However, V.S. Anand stated that they have been making progress with global tire customers and have incremental volumes starting to accrue from new approvals.
New approvals are coming from both US and European markets, indicating positive momentum in order inflows.
There is an expectation of gradual volume buildup from Q4 FY'24 and into FY'25.
Discussions with customers are ongoing, and the company is cautiously optimistic about growth in export volumes.
No specific quantitative details on order book or pending orders are disclosed in the provided transcript.

See what NOCIL Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is continuously evaluating various capex plans and growth initiatives but has not finalized anything yet.
Once a plan is approved by the Board, the company will announce it.
Current capex is under study with a focus on where investments are needed, including potential new products and expansions.
Expansion is considered when capacity utilization reaches around 70%-75%, but no immediate plans have been finalized.
The company is also exploring other adjacencies outside its core business but no definite timeline is available for such initiatives.
Maintenance capex is ongoing, but exact figures or commitments for the next two years have not been disclosed.
Aspiration to grow is strong, and they are assessing opportunities before committing to investment decisions.

Track NOCIL Ltd — get its next earnings analysis in your feed

How does NOCIL Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisNOCIL Ltd

Rev 4Mar 3

See where NOCIL Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does NOCIL Ltd rank in Chemicals & Petrochemicals?

Compare NOCIL Ltd against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What NOCIL Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →